Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 26, 2022

SELL
$4.33 - $7.45 $247,251 - $425,409
-57,102 Closed
0 $0
Q1 2022

May 10, 2022

SELL
$5.84 - $13.61 $45,423 - $105,858
-7,778 Reduced 11.99%
57,102 $333,000
Q4 2021

Feb 08, 2022

SELL
$12.52 - $19.02 $318,195 - $483,393
-25,415 Reduced 28.15%
64,880 $841,000
Q3 2021

Nov 15, 2021

SELL
$10.47 - $20.87 $190,229 - $379,187
-18,169 Reduced 16.75%
90,295 $1.23 Million
Q2 2021

Aug 11, 2021

BUY
$13.9 - $22.58 $1.51 Million - $2.45 Million
108,464 New
108,464 $2.32 Million

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $16.3M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track This Portfolio

Track Mirae Asset Global Investments Co., Ltd. Portfolio

Follow Mirae Asset Global Investments Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mirae Asset Global Investments Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Mirae Asset Global Investments Co., Ltd. with notifications on news.